{"id":77495,"date":"2013-01-30T13:41:43","date_gmt":"2013-01-30T13:41:43","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=77495"},"modified":"2026-04-03T10:28:06","modified_gmt":"2026-04-03T10:28:06","slug":"vanzari-globale-ale-roche-au-crescut-cu-4-in-2012","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=77495","title":{"rendered":"V\u00e2nz\u0103ri globale ale Roche au crescut cu 4% \u00een 2012"},"content":{"rendered":"<p>&#8220;Un moment important \u00een anul 2012 l-a constituit aprobarea unei noi terapii care prelunge\u015fte via\u0163a pacientelor cu cancer de s\u00e2n HER2 pozitiv. Acum, privim spre viitor \u015fi a\u015fteptam aprobarea unei alte noi terapii Roche pentru pacientele cu cancer de s\u00e2n&#8221;, a declarat Severin Schwan, CEO al Roche.<\/p>\n<p>V\u00e2nz\u0103rile Diviziei de Farmaceutice a Grupului Roche, \u00een anul 2012, au crescut cu 5%, la o rat\u0103 de schimb constant\u0103, ajung\u00e2nd la 35,2 miliarde de franci elve\u0163ieni. Aceast\u0103 cre\u015ftere s-a datorat \u00een special medicamentelor oncologice, ale c\u0103ror v\u00e2nz\u0103ri au crescut cu 9%. Produsele destinate tratamentului poliartritei reumatoide \u015fi hepatitelor virale au sus\u0163inut la r\u00e2ndul lor cre\u015fterea v\u00e2nz\u0103rilor Diviziei de Farmaceutice. \u00cen plus, Roche \u015fi-a \u00eent\u0103rit franciza HER 2 pentru tratamentul cancerului de s\u00e2n prin lansarea unui nou medicament \u00een Statele Unite, ce a primit de asemenea opinie pozitiv\u0103 \u00een Europa, unde urmeaz\u0103 a fi aprobat \u00een cur\u00e2nd.<\/p>\n<p>Pentru anul 2013, Grupul Roche estimeaz\u0103 c\u0103 v\u00e2nz\u0103rile sale vor cre\u015fte \u00eentr-un ritm similar cu cel \u00eenregistrat \u00een anul 2012, la o rat\u0103 de schimb constant\u0103.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Concernul farmaceutic elve\u0163ian Roche anun\u0163\u0103 o cre\u015ftere a v\u00e2nz\u0103rilor grupului, \u00een anul 2012, cu 4%, la o rat\u0103 de schimb constant\u0103, ajung\u00e2nd la 45,5 miliarde de franci elve\u0163ieni, pe seama produselor din portofoliul de oncologie \u015fi v\u00e2nz\u0103rilor testelor de diagnostic pentru laboratoarele clinice.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[8088,8760,518,8623],"class_list":["post-77495","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-farma","tag-oncologice","tag-rezultate","tag-roche"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/77495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=77495"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/77495\/revisions"}],"predecessor-version":[{"id":90825,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/77495\/revisions\/90825"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=77495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=77495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=77495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}